Biblio

2024
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, et al. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring. Nat Commun. 2024;15(1):3302.
Zhao L-L, Luo J-J, Cui J, Li X, Hu R-N, Xie X-Y, Zhang Y-J, Ding W, Ning L-J, Luo J-C, et al. Tannic Acid-Modified Decellularized Tendon Scaffold with Antioxidant and Anti-Inflammatory Activities for Tendon Regeneration. ACS Appl Mater Interfaces. 2024.
Guo R, Liu H, Su R, Mao Q, Zhao M, Zhang H, Mu J, Zhao N, Wang Y, Hao Y. Tanreqing injection inhibits influenza virus replication by promoting the fusion of autophagosomes with lysosomes: An integrated pharmacological study. J Ethnopharmacol. 2024:118159.
Yang J, Gong X, Li T, Xia Z, He R, Song X, Wang X, Wu J, Chen J, Wang F, et al. Tantalum Particles Promote M2 Macrophage Polarization and Regulate Local Bone Metabolism via Macrophage-Derived Exosomes Influencing the Fates of BMSCs. Adv Healthc Mater. 2024:e2303814.
Wang Q, Zhang R, He Y, Mao G, Kong Z. Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway. Int J Radiat Biol. 2024:1-11.
Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024.
Fatima N, Umar M, Ambreen S, Shaququzzaman M, Alam MMumtaz, Ali R. Targeted Cancer Stem Cell Therapeutics: An Update. Curr Top Med Chem. 2024.
Ke F, Benet ZL, Shelyakin P, Britanova OV, Gupta N, Dent AL, Moore BB, Grigorova IL. Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells. Proc Natl Acad Sci U S A. 2024;121(5):e2304020121.
Karbassi E, Padgett R, Bertero A, Reinecke H, Klaiman JM, Yang X, Hauschka SD, Murry CE. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cell Mol Life Sci. 2024;81(1):95.
Jiang Y, Yu M, Song Z-F, Wei Z-Y, Huang J, Qian H-Y. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomedicine. 2024;19:2553-2571.
Zhang Z, Zhang S, Wong HTing, Li D, Feng B. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight. BioDrugs. 2024.
Glaser KM, Egg M, Hobitz S, Mitterer M, Schain-Zota D, Schönberger K, Schuldes K, Cabezas-Wallscheid N, Lämmermann T, Rambold A, et al. Targeted Metabolomics on Rare Primary Cells. J Vis Exp. 2024;(204).
de Vries ISNaarmann, Dieterich C. Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination. Methods Mol Biol. 2024;2765:127-142.
Eichholz T, Heubach F, Arendt A-M, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunol Immunother. 2024;73(1):19.
Yang Q, Gao W, Li X, Li X, Zhou X, Li W, Zhou C, Luo A, Liu Z. Targeting ABCA1 via Extracellular vesicle-Encapsulated Staurosporine as a Therapeutic Strategy to enhance Radiosensitivity. Adv Healthc Mater. 2024:e2400381.
Chen X, Sun X, Ge Y, Zhou X, Chen J-F. Targeting adenosine A receptors for early intervention of retinopathy of prematurity. Purinergic Signal. 2024.
Huang T, Lu Z, Wang Z, Cheng L, Gao L, Gao J, Zhang N, Geng C-A, Zhao X, Wang H, et al. Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow. Nat Commun. 2024;15(1):3769.
Du J, Wang Y, Wu C, Zhang X, Zhang X, Xu X. Targeting bone homeostasis regulation: potential of traditional Chinese medicine flavonoids in the treatment of osteoporosis. Front Pharmacol. 2024;15:1361864.
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, Singh G, Sharma A, Rao N, Kaushik D. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier. Oncol Res. 2024;32(5):877-897.
Alcala S, Villarino L, Ruiz-Cañas L, Couceiro JR, Martínez-Calvo M, Palencia-Campos A, Navarro D, Cabezas-Sainz P, Rodriguez-Arabaolaza I, Cordero-Barreal A, et al. Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy. J Exp Clin Cancer Res. 2024;43(1):33.
Zhang X, Lao M, Yang H, Sun K, Dong Y, He L, Jiang X, Wu H, Jiang Y, Li M, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024.
Mukhtar AB, Morgan HJ, Gibbs A, Davies GE, Lovatt C, Patel GK. Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol. 2024.
Mediratta K, El-Sahli S, Marotel M, Awan MZ, Kirkby M, Salkini A, Kurdieh R, Abdisalam S, Shrestha A, Di Censo C, et al. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol. 2024;15:1366197.
Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A, Chhokar A, Aggarwal N, Bharti AChandra. Targeting Cervical Cancer Stem Cells by Phytochemicals. Curr Med Chem. 2024.
Cancilla D, Rettig MP, Karpova D, Thakellapalli H, Singh M, Meyers MJ, Ruminski PG, Christ S, Chendamarai E, Gao F, et al. Targeting CXCR4, VLA-4 and CXCR2 for Hematopoietic Stem Cell Mobilization. Blood Adv. 2024.

Pages